Toronto Dominion Bank
MRNA icon

Toronto Dominion Bank’s Moderna MRNA Stock Holding History

Toronto Dominion Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97M Buy
70,922
+8,910
+14% +$461K 0.01% 937
2026
Q1 		$3.15M Sell
62,012
-15,760
-20% -$735K ﹤0.01% 999
2025
Q4 		$2.29M Sell
77,772
-203
-0.3% -$5.51K ﹤0.01% 1080
2025
Q3 		$2.01M Sell
77,975
-5,365
-6% -$150K ﹤0.01% 1044
2025
Q2 		$2.3M Sell
83,340
-41,586
-33% -$1.1M ﹤0.01% 943
2025
Q1 		$3.54M Sell
124,926
-49,094
-28% -$1.74M 0.01% 781
2024
Q4 		$7.24M Buy
174,020
+42,543
+32% +$2.03M 0.01% 615
2024
Q3 		$8.79M Buy
131,477
+25,177
+24% +$2.31M 0.02% 497
2024
Q2 		$12.6M Sell
106,300
-27,477
-21% -$3.48M 0.02% 426
2024
Q1 		$14.3M Sell
133,777
-65,955
-33% -$6.65M 0.02% 406
2023
Q4 		$19.9M Buy
199,732
+55,595
+39% +$4.68M 0.03% 378
2023
Q3 		$14.9M Sell
144,137
-12,083
-8% -$1.35M 0.02% 409
2023
Q2 		$19M Sell
156,220
-8,521
-5% -$1.14M 0.03% 380
2023
Q1 		$25.3M Buy
164,741
+11,927
+8% +$1.97M 0.04% 273
2022
Q4 		$27.4M Buy
152,814
+560
+0.4% +$91.6K 0.04% 270
2022
Q3 		$18M Sell
152,254
-29,105
-16% -$4.42M 0.03% 321
2022
Q2 		$25.9M Sell
181,359
-31,688
-15% -$4.53M 0.05% 218
2022
Q1 		$36.7M Buy
213,047
+2,027
+1% +$341K 0.06% 182
2021
Q4 		$53.6M Sell
211,020
-100,848
-32% -$29.5M 0.07% 182
2021
Q3 		$120M Buy
311,868
+268,070
+612% +$98.9M 0.19% 79
2021
Q2 		$10.3M Buy
43,798
+5,335
+14% +$953K 0.02% 454
2021
Q1 		$5.04M Sell
38,463
-14,559
-27% -$2.11M 0.01% 578
2020
Q4 		$5.54M Buy
53,022
+6,538
+14% +$661K 0.01% 578
2020
Q3 		$3.29M Buy
46,484
+5,051
+12% +$352K 0.01% 622
2020
Q2 		$2.66M Buy
+41,433
New +$2.27M 0.01% 695

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Toronto Dominion Bank's MRNA Position: Q2 2026 in Review

Toronto Dominion Bank increased its Moderna (MRNA) stake by 14% in Q2 2026, buying an estimated $461K and bringing the position to 70,922 shares worth $4.97M. The position accounts for 0.01% of the portfolio, ranked #937.

Toronto Dominion Bank first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $120M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Toronto Dominion Bank held 70,922 shares of Moderna worth $4.97M as of Q2 2026.
  • Toronto Dominion Bank bought 8,910 Moderna shares in Q2 2026, an estimated $461K.
  • Moderna made up 0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #937 holding.
  • Toronto Dominion Bank first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • Toronto Dominion Bank's Moderna position peaked at $120M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.